In general, we demonstrated that increased expression of GLNM regulators was associated with a cold tumor immune microenvironment in almost all cancer types and upregulated PD-L1 expression in ACC, KICH, KIRC, LGG, LIHC, MESO, and SARC, which implied a positive association with immunotherapeutic responsiveness. The gene discussed is CD274; the disease is neoplasm.